To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Use of platelet-rich plasma for treatment of symptomatic degenerative lumbar disease

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2016

Use of platelet-rich plasma for treatment of symptomatic degenerative lumbar disease

Vol: 5| Issue: 4| Number:5| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Lumbar intradiskal platelet-rich plasma (PRP) injections: a prospective, double-blind, randomized controlled study

PM R. 2016 Jan;8(1):1-10

Contributing Authors:
YA Tuakli-Wosornu A Terry K Boachie-Adjei JR Harrison CK Gribbin EE LaSalle JT Nguyen JL Soloman GE Lutz

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

58 patients with low back pain due to degenerative lumbar disease were randomized to intradiscal injection of 1-2mL of either platelet-rich plasma (PRP) or contrast agent (Omnipaque 180). The purpose of this study was to evaluate the efficacy of PRP for improvement of measures of pain and function relative to a nonactive injection. Follow-up was performed over 8 weeks post-injection. Results after...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.